Get started
RocketTickers

Halozyme Announces Janssen Receives FDA Approval Of DARZALEX FAS

Long
Halozyme Therapeutics, Inc. (NASDAQ:HALO)  
RocketTickers  
NASDAQ:HALO   Halozyme Therapeutics, Inc.
Beyond Technical Analysis
0
0
beyondta
HALO: Halozyme Therapeutics, Inc.
2021-01-15 17:00:00
Halozyme Announces Janssen Receives FDA Approval Of DARZALEX FASPRO® (Daratumumab And Hyaluronidase-fihj) As Treatment For Newly Diagnosed Patients With Light Chain (AL) Amyloidosis
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.